{{Expand Russian|Хифенадин|date=April 2017}}
{{Distinguish|quinidine}}
{{Drugbox
| drug_name = 
| IUPAC_name = 1-Azabicyclo[2.2.2]octan-3-yl(diphenyl)methanol
| image = Quifenadine structure.svg
| width = 165

<!--Clinical data -->
| tradename = Fencarol
| Drugs.com = 
| MedlinePlus = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| routes_of_administration = Oral ([[Tablet (pharmacy)|tablets]]),  [[Intramuscular injection|IM injection]]
| legal_status = [[Over-the-counter drug|OTC]] (tablets), ℞-only (solution for IM injection) <small>([[Russia|RU]])</small>

<!--Pharmacokinetic data -->
| bioavailability = 45% ([[Cmax (pharmacology)|T<sub>max</sub>]] = 1 hour)<ref name = "PI">{{cite web|title=Fencarol (quifenadine) Tablets, for Oral Use. Full Prescribing Information|url=http://grls.rosminzdrav.ru/ImgInstr.aspx?folder=ScanVavilova&Filepath=\Vneseno_v_Grls\442006\IP&idReg=86466&isOld=1&fileType=jpg&pfolder=2|website=State Register of Medicines|accessdate=4 January 2016|language=Russian}}</ref>
| protein_bound = 
| metabolism = [[Liver]]
| elimination_half-life = 
| excretion =

<!--Identifiers -->
| CAS_number = 10447-38-8
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = W9A18RJ49B
| PubChem = 65600
| ChemSpiderID = 59041
| ATCvet = 
| ATC_prefix = R06
| ATC_suffix = AX31
| DrugBank =
| KEGG = D10230
| ChEMBL = 1187694
| synonyms = 3-Quinuclidinyldiphenylmethanol

<!--Chemical data -->
| C=20 | H=23 | N=1 | O=1
| molecular_weight = 293.40 g/mol
| smiles= OC(c1ccccc1)(c2ccccc2)C4C3CCN(CC3)C4
| StdInChI = 1S/C20H23NO/c22-20(17-7-3-1-4-8-17,18-9-5-2-6-10-18)19-15-21-13-11-16(19)12-14-21/h1-10,16,19,22H,11-15H2
| StdInChIKey = PZMAHNDJABQWGS-UHFFFAOYSA-N
}}

'''Quifenadine''' ({{lang-rus|хифенадин}}, trade name: '''Phencarol''', '''Фенкарол''') is an 2nd generation [[H1 antagonist|antihistamine]] drug, marketed mainly in [[Post-Soviet states|post-Soviet countries]].<ref>{{cite web|url=http://www.drugs.com/international/quifenadine.html |title=Quifenadine |website=Drugs.com |accessdate=28 January 2014 |author=<!--Staff editor(s); no by-line-->}}</ref><ref>{{cite journal|pmid=19487925 |year=2010 |last1=Makarov |first1=L. |last2=Balykova |first2=L. |last3=Soldatova |first3=O. |last4=Komolyatova |first4=V. |last5=Serebruany |first5=V. |title=The antiarrhythmic properties of quifenadine, H1-histamine receptor blocker in children with premature beats: A randomized controlled pilot trial |volume=17 |issue=4 |pages=396–401 |doi=10.1097/MJT.0b013e3181a86987 |journal=American journal of therapeutics}}</ref> Chemically, it is a [[quinuclidine]] [[derivative (chemistry)|derivative]].

== Indications ==
* [[Allergic rhinitis]]
* Acute and chronic [[urticaria]]
* [[Angioedema]]
* [[Dermatitis]]
* [[Atopic dermatitis]]
* [[Itch|Pruritus]]<ref name = "PI" />

==References==
{{Reflist|2}}


{{Antihistamines}}
{{Histaminergics}}

[[Category:Quinuclidines]]
[[Category:Antihistamines]]
[[Category:Alcohols]]
[[Category:Russian drugs]]


{{respiratory-system-drug-stub}}